Trump Tariff Block: Analyst Bullish on TCS, L&T, Bajaj Auto
The recent news of the US court’s reversal of Trump’s tariff orders has sent shockwaves across the global trade landscape. The move is seen as a significant shift in global trade dynamics, and Indian exporters are likely to benefit from this development. According to investment advisor Adarsh Nimborkar, this legal intervention could lead to a near-term upside in stocks like TCS, Bajaj Auto, L&T, and Sun Pharma.
The Trump administration had imposed tariffs on various Indian goods, including steel and aluminum, citing national security concerns. However, the US Court of International Trade (CIT) has now blocked these tariffs, ruling that the president exceeded his authority in imposing them. The CIT’s decision is a major blow to the Trump administration’s efforts to impose tariffs on Indian goods, and it is likely to have far-reaching implications for India’s exports.
The Indian rupee has already appreciated against the US dollar following the news, and the stock market is also expected to benefit from this development. Analysts believe that the reversal of tariffs will lead to an increase in exports, which will boost the economy and drive up stock prices.
TCS, India’s largest software services company, is likely to benefit from the reversal of tariffs. The company has a significant presence in the US market and relies heavily on exports to drive its growth. A reduction in tariffs will lead to increased demand for its services, which will drive up its stock price.
Bajaj Auto, India’s leading two-wheeler manufacturer, is another stock that is expected to benefit from the reversal of tariffs. The company has a significant presence in the US market, and a reduction in tariffs will lead to increased demand for its products. Additionally, the company’s focus on exporting to countries like the US, Europe, and Latin America will benefit from the reversal of tariffs.
L&T, India’s largest engineering and construction company, is also likely to benefit from the reversal of tariffs. The company has a significant presence in the US market, and a reduction in tariffs will lead to increased demand for its services. Additionally, the company’s focus on exporting to countries like the US, Europe, and Latin America will benefit from the reversal of tariffs.
Sun Pharma, India’s largest pharmaceutical company, is another stock that is expected to benefit from the reversal of tariffs. The company has a significant presence in the US market, and a reduction in tariffs will lead to increased demand for its products. Additionally, the company’s focus on exporting to countries like the US, Europe, and Latin America will benefit from the reversal of tariffs.
In conclusion, the recent news of the US court’s reversal of Trump’s tariff orders is a significant development that is likely to benefit Indian exporters. Stocks like TCS, Bajaj Auto, L&T, and Sun Pharma are expected to benefit from this development, and investors may want to consider adding these stocks to their portfolios.
